Inventor · disambiguated record
Guo Ping Wei
Also filed as: WEI GUO · WEI GUO P · WEI GUO PING
31 granted patents·8 pending applications·285 citations·filing 1998–2024
97Inventor score
Top patents by PatentIndex Score
39 records- 0194US6207665B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 1998·Granted Mar 27, 2001·89 cites·11 claims
- 0293US11492358B1Macrocyclic indole derivativesBAYER AG·Filed 2021·Granted Nov 8, 2022·3 cites·18 claims
- 0392US10981932B2Macrocyclic indole derivativesBAYER AG·Filed 2017·Granted Apr 20, 2021·9 cites·17 claims
- 0492US9315509B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2014·Granted Apr 19, 2016·17 cites·20 claims
- 0592US7737145B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseESTRELLITA PHARMACEUTICALS LLC·Filed 2006·Granted Jun 15, 2010·32 cites·10 claims
- 0690US11891404B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2022·Granted Feb 6, 2024·1 cites·10 claims
- 0790US11267819B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2020·Granted Mar 8, 2022·2 cites·21 claims
- 0890US8569303B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseARNAIZ DAMIAN O·Filed 2010·Granted Oct 29, 2013·19 cites·12 claims
- 0990US6861424B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2002·Granted Mar 1, 2005·19 cites·60 claims
- 1089US6555537B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Apr 29, 2003·24 cites·3 claims
- 1188US12152041B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2022·Granted Nov 26, 2024·1 cites·6 claims
- 1288US6534509B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Mar 18, 2003·19 cites·4 claims
- 1388US2025296935A1Diamine Derivatives as Inhibitors of Leukotriene A4 HydrolaseCELLTAXIS LLC·Filed 2024·Application pending·0 cites
- 1487US11440923B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2018·Granted Sep 13, 2022·3 cites·15 claims
- 1586US11478451B1Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Oct 25, 2022·3 cites·16 claims
- 1686US11401278B2Macrocyclic indole derivativesBROAD INST INC·Filed 2018·Granted Aug 2, 2022·3 cites·13 claims
- 1785US11447504B2Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Sep 20, 2022·3 cites·14 claims
- 1885US11286263B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2018·Granted Mar 29, 2022·3 cites·9 claims
- 1982US7220856B2Substituted quinoline CCR5 receptor antagonistsSCHERING AG·Filed 2003·Granted May 22, 2007·22 cites·8 claims
- 2082US7026323B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2004·Granted Apr 11, 2006·8 cites·7 claims
- 2181US12173009B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 2272US6541476B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Apr 1, 2003·3 cites·9 claims
- 2367US6995156B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2004·Granted Feb 7, 2006·2 cites·20 claims
- 2465US2018230159A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2018·Application pending·0 cites
- 2561US2013123243A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2012·Application pending·0 cites
- 2660US7268140B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2005·Granted Sep 11, 2007·0 cites·11 claims
- 2760US2016272649A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2016·Application pending·0 cites
- 2856US6977258B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2003·Granted Dec 20, 2005·0 cites·19 claims
- 2956US6972290B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2003·Granted Dec 6, 2005·0 cites·23 claims
- 3054US6982259B2N-heterocyclic derivatives as NOS inhibitorsSCHERING AG·Filed 2003·Granted Jan 3, 2006·0 cites·15 claims
- 3153US7202263B2N-heterocyclic derivatives as NOS inhibitorsSCHERING AG·Filed 2005·Granted Apr 10, 2007·0 cites·15 claims
- 3253US7084142B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2006·Granted Aug 1, 2006·0 cites·15 claims
- 3353US6573266B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Jun 3, 2003·0 cites·4 claims
- 3452US7056923B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2003·Granted Jun 6, 2006·0 cites·16 claims
- 3549US12338250B2Methods of preparing macrocyclic indolesBROAD INST INC·Filed 2020·Granted Jun 24, 2025·0 cites·20 claims
- 3645US2005101644A1Benzylether amine compounds useful as CCR-5 antagonistsSCHERING AG·Filed 2004·Application pending·0 cites
- 3743US2021253598A1Aryl annulated macrocyclic indole derivativesBAYER AG·Filed 2018·Application pending·0 cites
- 3842US2007155727A1Amide inhibitors of leukotriene A4 hydrolaseSCHERING AKTIENGESSELLSCHAFT·Filed 2006·Application pending·0 cites
- 3938US2006167044A1Piperidine derivatives and their use as anti-inflammatory agentsARNAIZ DAMIAN O·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guo Ping Wei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →